The novel class of GLP-1 agonist medication and GIP co-agonist medications, including tirzepatide, semaglutide, and the newly introduced retatrutide, provide groundbreaking progress in the treatment . https://kpv-peptide225200.uzblog.net/semaglutide-the-comparative-review-57405213